LIVE — Last crawled: 2026-09-29 17:35 JST
Vol.1 — September 30, 2026
MSC Portal ›Regulatory Watch› All Entries (15)
Standards, Guidance & Notices
Showing 11–15 of 15
IMDRF
IMDRF/AIML WG/N88 FINAL:2025
Good machine learning practice for medical device development: Guiding principles
PUBLISHED AI / Machine Learning
Final document of the IMDRF AI/ML-enabled Working Group setting out 10 guiding principles for Good Machine Learning Practice (GMLP), intended to promote the development of safe, effective, and high-quality AI-enabled medical devices across the total product life cycle. The principles cover: understanding the intended use and leveraging multidisciplinary expertise; good software engineering, medical device design, and security practices; clinical evaluation using datasets representative of the intended patient population; independence of training and test datasets; fit-for-purpose reference standards; model choice and design tailored to the available data and intended use; assessment focused on human-AI interactions and the performance of the human-AI team rather than the device in isolation; testing under clinically relevant conditions; clear, essential information for users; and monitoring of deployed models and management of re-training risks. The document presents the principles as a call to action for standards organizations, regulators, and other bodies to further advance GMLP, and notes that generative AI may heighten their importance.
Published: 2025-01-29
FDA
CDRH
FDA-AI-DSF-Draft-2025
Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations
DRAFT AI / Machine Learning
FDA draft guidance (January 2025) on lifecycle management and marketing submissions for AI/ML-enabled SaMD. It provides specific recommendations on training data management, performance monitoring, and change management (PCCP: Predetermined Change Control Plan), including recommendations on handling adaptive algorithms and on describing postmarket performance monitoring plans. Still at the draft stage, pending finalization.
Published: 2025-01-07
JFMDA
Notice
jfmda_20241226_146b6000
Guidance for Companies on the Development of AI Medical Devices Using Pseudonymously Processed Information, Version 1.0
PUBLISHED AI / Machine Learning
On December 25, 2024, Team 1 of the JFMDA Subcommittee on Handling of Personal Information compiled and published the "Guidance for Companies on the Development of AI Medical Devices Using Pseudonymously Processed Information, Version 1.0." On the same date, the Medical Device Evaluation Division of the MHLW Pharmaceutical Safety Bureau issued an administrative notice providing information on the guidance. As explained in Chapter 0 (Background and Purpose) of the guidance, developing AI-enabled medical devices generally requires large volumes of medical data, such as clinical information, images (CT, MRI, etc.), and other non-text information (ECG, EEG, etc.). However, medical information held by medical institutions generally constitutes personal data under the Act on the Protection of Personal Information, and it is usually not collected for the purpose of AI medical device research and development.
Published: 2024-12-26
FDA
CDRH
FDA-PCCP-AI-DSF-2024
Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions
FINAL AI / Machine Learning
FDA final guidance (December 2024) on Predetermined Change Control Plans (PCCPs), which streamline change management for AI-enabled medical devices. Modifications described in an authorized PCCP can be implemented without a new premarket submission for each change. It specifies the three elements a PCCP should include: a description of modifications, a modification protocol, and an impact assessment. It puts into practice the statutory framework of section 515C of the FD&C Act, added by FDORA.
Published: 2024-12-04
IMDRF
IMDRF/AIMD WG/N67 (Edition 1)
Machine Learning-enabled Medical Devices: Key Terms and Definitions
PUBLISHED AI / Machine Learning
Edition 1 of the IMDRF Artificial Intelligence Medical Devices (AIMD) Working Group document on key terms and definitions for Machine Learning-enabled Medical Devices (MLMD). It establishes terms and definitions across the total product life cycle to promote consistency, support global harmonization, and provide a foundation for future guidelines on MLMD. Section 5 provides key definitions relevant to machine learning used in medical devices (including the definition of MLMD), Section 6 gives definitions from technical standards (e.g., bias, continuous learning, reference standard, reinforcement learning), and Section 7 discusses common machine learning terms. Most terms were previously defined in GHTF documents or internationally recognized AI standards, while some were developed or discussed by the AIMD Working Group. The document also notes that the term "bias" is used differently in data science and in legal discussions.
Published: 2022-05-09
‹ 1 2